MaineHealth
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, MaineHealth sits in the top decile of US sponsors by registered trial count (#604 of 15,742 sponsors by registered trial count).
MaineHealth: 26 sponsored US clinical trials, 1 recruiting.
MaineHealth sponsors 26 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 19 completed. 3 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 3 trials.
Top-decile sponsor footprint
MaineHealth ranks in the top decile of sponsors by registered trial count (#604 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
19 of 23 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (82.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
26 total, page 1 of 1
Immunoinflammatory Response in Post Cardiac Arrest Syndrome (PCAS)
NCT02664831
Short Interval Resveratrol Trial in Cardiovascular Surgery
NCT03762096
Comparative Study of Simulation Technologies for Use in Neonatal Resuscitation Training for Rural Hospitals
NCT07228494
Giving Healthy Meal Kits and Cooking Lessons to Rural Families With Food Insecurity.
NCT06869993
Comparison of PKs of 17-Beta-Estradiol Via Sublingual Placement Versus Swallowing in Male-to-Female Transgender Patients
NCT05428215
The Effect of Buprenorphine Continuation for Patients With Opioid Use Disorder
NCT04981678
Telemedicine to Reduce Disparities in the Identification and Treatment of Neonatal Encephalopathy
NCT05155111
Echocardiographic Risk Factors of Stroke in Patients With Atrial Fibrillation
NCT03824509
Effects of Mediterranean Diet Intervention in Diabetic Heart Disease
NCT03757845
The Impact of Holding on Stress and Bonding in Mother-Infant Pairs During Therapeutic Hypothermia
NCT03837717
Telemedicine to Improve Use of Therapeutic Hypothermia in Rural Settings
NCT03706417
OMT to Improve Feeding After Hypothermia
NCT03380013
Treatment of HFpEF With Nitrate Supplement
NCT03289481
A Study of Tobacco Smoke and Children With Respiratory Illnesses
NCT03062709
A Pilot Study Evaluating the Use of mTor Inhibitor Sirolimus in Children and Young Adults With Desmoid-Type Fibromatosis
NCT01265030
Twice Daily Versus Twice Weekly Soak-and-Seal Baths in Pediatric Atopic Dermatitis
NCT03397979
The Effect of the Hemobag® Ultrafiltration System on Blood Conservation and Coagulation After Cardiopulmonary Bypass
NCT01435304
Testing Spread and Implementation of Novel Methicillin Resistant Staphylococcal Aureus (MRSA)-Reducing Practices
NCT01255943
Prophylaxis to Reduce Postoperative Atrial Fibrillation in Cardiac Surgery
NCT00953212
Family Exergaming: A Research Study Testing a Videogame Intervention to Increase Physical Activity for Families
NCT00889122
Reduction of Mortality Prior to and During the First 90 Days of Dialysis Through a Renal Rehabilitation Program
NCT00792454
Early Detection and Intervention for the Prevention of Psychosis
NCT00531518
"Generation Fit and Exerlearning With In the Groove"
NCT00424918
The Efficacy of Tamsulosin in the Treatment of Ureteral Stones in Emergency Department Patients
NCT00600405
Lamotrigine in Treatment Resistant Depression in Adolescents
NCT00284791
Psychosis: Early Detection, Intervention and Prevention
NCT01597141
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 3 | 1 |
| Phase 4 | 2 |
Therapeutic Areas
What is open in the MaineHealth pipeline
1 recruiting of 26 indexed (4% open); 19 completed (73%).
Phase mix: 3 late (III/IV) vs 2 early (I/II) (balanced across stages).
Top condition: Obesity (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
MaineHealth: open-pipeline peers nationwide
Peers matched on 26 registered trials and 4% open enrollment, not the therapeutic-area sidebar.
MaineHealth sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 26 trials (± recruiting share)
- Abbott Diabetes Care · 26 trials · 12% recruiting
- Aldeyra Therapeutics · 26 trials · 4% recruiting
- California Polytechnic State University-San Luis Obispo · 26 trials · 19% recruiting
- DexCom · 26 trials · 4% recruiting
Sponsors near 4% open enrollment (± trial volume)
- Medtronic Spinal and Biologics · 4% recruiting · 26 trials
- Oklahoma State University · 4% recruiting · 26 trials
- ViiV Healthcare · 4% recruiting · 182 trials
- Celgene · 4% recruiting · 308 trials
Related
What to do with this MaineHealth page
26 registered trials is a research-attention snapshot, not an endorsement of MaineHealth or any single study.
- 1 of MaineHealth's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition MaineHealth studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
MaineHealth pipeline card: 26 registered trials from official public datasets.Report a data error.